Apparatus, systems and methods for in vitro screening of complex biological fluids

US12566124B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12566124-B2
Application numberUS-202117793879-A
CountryUS
Kind codeB2
Filing dateJan 27, 2021
Priority dateJan 27, 2020
Publication dateMar 3, 2026
Grant dateMar 3, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosed apparatus, systems and methods relate to technology that provides a method for the assessment of the polymerization of a sample, e.g., whole blood or blood plasma coagulation, by a non-contact acoustic tweezing device via the application of a sweeping frequency to the levitating sample and the corresponding assessment of extracted sample parameters.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A noncontact in vitro method of analyzing a sample, comprising: levitating the sample using an acoustic carrier signal at a first frequency; perturbing the sample using an acoustic modulation signal at one or more second frequencies; measuring the oscillations of the sample resulting from the acoustic modulation signal to obtain amplitude measurements against time; analyzing amplitude measurements against time to calculate an extracted parameter; and filtering the amplitude measurements with a bandpass filter, wherein one or more second frequencies is a single frequency. 2 . The noncontact in vitro method of claim 1 , further comprising: repeating one or more steps with a fluid of known viscosity, wherein the one or more steps are selected from a list consisting of levitating the sample using an acoustic carrier signal at a first frequency, perturbing the sample using an acoustic modulation signal at one or more second frequencies, measuring the oscillations of the sample resulting from the acoustic modulation signal to obtain amplitude measurements against time, analyzing amplitude measurements against time to calculate an extracted parameter, and filtering the amplitude measurements with a bandpass filter. 3 . The noncontact in vitro method of claim 1 , further comprising generating a calibration curve using the extracted parameters of a fluid of known viscosity. 4 . The noncontact in vitro method of claim 1 , further comprising estimating at least one characteristic of the sample by plotting its extracted parameter on a calibration curve. 5 . The noncontact in vitro method of claim 4 , wherein the at least one characteristic is viscosity. 6 . The noncontact in vitro method of claim 1 , wherein the one or more second frequencies be between about 1000 Hz to about 10 Hz. 7 . The noncontact in vitro method of claim 1 , wherein the one or more second frequencies be between about 150 Hz to about 50 Hz. 8 . The noncontact in vitro method of claim 1 , wherein the amplitude measurements against time are analyzed by generating an AFR curve from which the extracted parameters are calculated. 9 . The noncontact in vitro method of claim 8 , wherein the extracted parameter is area under the curve (AUC), peak frequency (fpeak), peak amplitude (Apeak), lowest frequency at half-frequency width (f1/2left), highest frequency at half-frequency width (f1/2right), minimum amplitude (Amin), maximum amplitude (Amin), quality factor (QF) and fpeak, the sum of several Apeaks, the bandwidth of instability, and/or the AUC of instability. 10 . The noncontact in vitro method of claim 9 , wherein the QF is calculated by dividing a resonant frequency of the AFR over a frequency range centered on the resonant frequency. 11 . The noncontact in vitro method of claim 10 , wherein the resonant frequency is the frequency at which a maximum amplitude of the AFR curve is observed. 12 . The noncontact in vitro method of claim 10 , wherein the frequency range is between about 30% to about 70% of the frequency at which a maximum amplitude is observed. 13 . The noncontact in vitro method of claim 1 , wherein the amplitude measurements against time are measured with a viscous tweezograph. 14 . The noncontact in vitro method of claim 1 , wherein the biological sample is whole blood or blood plasma.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12566124B2 cover?
The disclosed apparatus, systems and methods relate to technology that provides a method for the assessment of the polymerization of a sample, e.g., whole blood or blood plasma coagulation, by a non-contact acoustic tweezing device via the application of a sweeping frequency to the levitating sample and the corresponding assessment of extracted sample parameters.
Who is the assignee on this patent?
The Administrators Of The Tulane Educational Fund
What technology area does this patent fall under?
Primary CPC classification G01N15/1429. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).